Dongcheng Pharmaceutical's subsidiary, Yunké Pharmaceutical, has begun customized production of Yttrium-90 radioisotopes. While this marks a new production capability, the current revenue generated from this specific product is relatively small. The company's statement indicates a nascent stage for this particular venture. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This is a product update from a company that is not a frontier AI lab, and the product itself is not a core AI development.